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Abstract: 
Progesterone is a steroid hormone that is responsible in the maintenance of pregnancy 
and prevention of preterm labor. The withdrawal of progesterone leads to the 
neuroinflammatory processes associated with cervical ripening and, ultimately, parturition[27]. 
Such actions of progesterone are thought to be exclusively mediated by binding to classical 
nuclear progesterone receptors (PR), even though progesterone also binds to glucocorticoid 
receptors (GR). The purpose of this study was to determine \Vhether PR and/or GR regulate 
neutrophil immigration as part of the inflammatory mechanism that mediates preterm 
parturition and remodeling of the cervix. Time-dated pregnant CD-1 mice were 
ovariectomized (Ovx) on day 16 postbreeding and treated with either a pure GR agonist 
(dexamethasone, Dex; 0.5mg/kg/day i.m.) or a progestagen that binds to both PR and GR 
(medroxyprogesterone acetate, MPA; 10mg/kg/day i.m.). Sham-operated and Ovx mice given 
vehicle capsules served as controls. Female mice were killed before or after birth in order to 
obtain cervical tissue from both pre- and post-partum cervices. The cervix was sectioned, 
stained, and analyzed for cell nuclei density, collagen content and resident neutrophils which 
were counted by image analysis. Mice treated with Dex delivered 24h postovariectomy on day 
17, as in Ovx controls. Similarly, mice given MPA delivered at normal term, as in Sham 
controls. The census of neutrophils in the cervix increased in Sham mice by day of birth (D 19), 
decreased inDex-treated mice before (Dl6.5) and after preterm birth, but was unaffected in 
mice after Ovx or MP A treatment. No differences were seen between groups when analyzed for 
either cell nuclei or extracellular matrix (ECM) suggesting these processes may not be 
regulated by PR or GR. These results do not support our hypothesis that neutrophil recruitment 
is associated with cervical remodeling in preterm. Additionally, although neutrophils may 
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affect the inflammatory response and degradation of the ECM in the cervix immediately 
leading up to birth, these results do not support our hypothesis that the PR and/or GR regulate 
neutrophil immigration in the process of preterm remodeling of the cervix or parturition. Thus, 
treatment with glucocorticoid receptor agonists are unlikely to be a useful treatment to block 
preterm cervical ripening or prevent preterm birth. This work supported in part by a NIH 
maternal and child health grant, HD054931. 
Introduction: 
Premature delivery affects 12.9% of all births and is the cause of at least 75% ofneonatal 
deaths[24]. Preterm birth is defined as birth prior to 37 weeks of gestation and is a significant 
contributor to perinatal morbidity and mortality yet the mechanisms by which birth occurs 
remain unclear. The cascade of events that culminate in spontaneous preterm birth has several 
potential underlying pathways. Four of these pathways, which are supported by clinical and 
experimental evidence, include excessive myometrial and fetal membrane over-distention, 
decidual hemorrhage, precocious fetal endocrine activation and intrauterine infection or 
inflammation[23]. 
The most optimistic prospect for reducing the incidence of preterm birth is clearly the 
prevention of preterm labor with the ultimate goal of eliminating neonatal complications and 
death[16, 23]. The risk of neonatal death is extremely high, and those who survive commonly 
suffer life-long physical and mental disabilities which arise as complications ofimmaturity[16]. 
A major complication commonly seen in preterm infants is the underdevelopment of the lungs. 
The development of the respiratory system is not fully completed until the last weeks of fetal 
with insufficient surfactant, a lipoprotein responsible for 
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reducing the alveolar surface tension, which is necessary for normal respiration to occur[lO]. 
Infants born prematurely frequently require resuscitation and Yentilation at birth. Although this 
is necessary for the survival of the premature infant, it can damage the immature lung and can 
prolong the infant's dependence upon mechanical ventilation. Furthermore, the immature lungs 
are forced to grow and develop in an environment that is drastically different than that inutero 
and at a time \\'hen the lungs are required for gas exchange[lO]. Lack of lung maturation at 
birth can lead to the inability for the premature infant to draw in its first breath which usually 
leads to death due to lack of oxygen delivery to the brain and other vital organs[8]. Hypoxia of 
vital organs can also put the infant at high risk for disabilities such as mental retardation, 
cerebral palsy, lung and gastrointestinal problems, vision and hearing loss[25]. Current 
management techniques are aimed at maintaining the pregnancy for a longer period oftime so 
that the fetus can fully grow and develop in-utero before parturition. 
Multiple efforts have failed to establish a single effective treatment for preterm labor, 
partly because the mechanisms regulating the uterus and cervix during pregnancy are not well 
understood[7]. Because the contracting uterus is the most frequently recognized antecedent of 
preterm birth, stopping contractions has been the focus oftherapeutic approaches[23J. The 
inhibition of myometrial contractions is called tocolysis, and a drug administration to that end 
is referred to as a tocolytic agent. In the three decades tocolytics have been in use, none of the 
agents have lived up to the expectation that prematurity rates would be reduced by these drugs. 
Although more than 80% of women with preterm labor who are treated with tocolytic agents 
are able to maintain their pregnancies for an additional 24-48 hours after the drugs are 
administered, few data suggest that tocolysis maintains pregnancy for a longer period [23]. 
Additionally, tocolytics may have serious side effects including but not limited to arrhythmias 
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in the mother and fetus, heart failure, chest pain, and shortness of breath. A further attempt to 
decrease neonatal morbidity and mortality is to speed up the production of surfactant in the 
lungs. To this effect, corticosteroids are administered to the mother between 24 and 34 weeks 
of gestation. Currently, corticosteroid therapy is the only treatment shown to improve fetal 
survival[24]. In a small trial study of pregnant women treated with corticosteroids, no 
premature induction of labor or cervical ripening was seen[12]. However, there is no clear 
evidence explaining the role of corticosteroids and glucocorticoid receptors in the maintenance 
of pregnancy and an unripe cervix or cervical ripening and the induction of labor. The use of 
progestational agents to prevent preterm birth among women with risk factors other than 
previous preterm birth is currently an area of active research. Fonseca et al. reported that daily 
administration ofvaginal progesterone reduced the frequency of birth before 34 weeks of 
gestation by more than 40% among asymptomatic women with a short cervix as seen on 
ultrasonography[23]. In February 2011, the FDA approved a synthetic progesterone drug, 
termed Makena, which has been shown to prevent preterm labor. Unfortunately, at this time the 
drug is extremely expensive (ranging from $690 - $1500 per dosage) and is not being 
administered acutely to women presenting with preterm birth. Currently, the drug is being 
given to women who have experienced preterm labor in the past and are thus, at higher risk for 
going into preterm labor once again. 
Speculations regarding preterm birth are usually focused around asking questions about 
the mechanism and determining the "how" and "why" premature birth occurs. Gonzales et al. 
hypothesized that preterm cervical ripening may be due to an aberrant regulation in timing of 
the same processes that occur at term, or may result from unique molecular mechanisms[9]. It 
has been proposed that the earlier activation of the same key biochemical pathways accounting 
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for full term cervical ripening occur in preterm cervical ripening. At this time, it is unknown 
whether preterm cervical ripening is just an abnormal regulation in timing, or whether 
divergent mechanisms and pathways are involved in preterm versus full term birth[9]. 
In order to better identify the approximate time of the initiation of parturition, researchers have 
begun to separate parturition into various identifiable phases. The term parturition encompasses 
all aspects of the birthing process[16]. In the first phase, phase 0, the uterus is unresponsive to 
contractile stimuli and remains in a quiescent state. 
The cervix begins to grow and swell (edema) while 
the collagen content is actually increasing in order 
to account for the hypertrophy of the tissue. In phase 
1, the myometrium undergoes multiple changes 
which collectively bring about increased 
responsiveness, and the cervix begins to show a 
decrease in the collagen content, preparing for the 
r ------·-··--:-·--·, 
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cervix to become more elastic and dilated Phase 1 appears to last for several days before the 
start of phase 2 and compromises the first 95% of pregnancy. Phase 2 is the time of active labor 
with an associated inflammatory response and the continuation of the degradation of the 
collagen matrix. Phase 3 follows delivery of the fetus; it is the time of uterine involution where 
the cervix is repairing itself and returning to its non-pregnant, unripe state. It is during this 
stage, the collagen content begins to rebuild itself and immune cells tend to disperse[16]. 
Cervical ripening is known to be characterized by three main changes in the cervix: 
growth ofthe cervical tissue (hypertrophy of the cervix), an increase in immune cells to the 
area (inflammatory response) as well as the degradation of the extracellular collagen matrix. 
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During gestation, the rigid, collagen-rich cervix acts as a gatekeeper between the fetus and the 
outside world(26]. However, towards the end of pregnancy, the collagen within the cervix 
begins to break down. This degradation of collagen matrix, known as collagenolysis, causes the 
cervix to become more soft and elastic, allowing it to relax and dilate in preparation for the 
fetus to exit the vaginal canal. This process, known as cervical ripening, provides a safe and 
relatively easy way for the fetus to travel through the cervix[14]. Failure of the cervix to ripen 
and remodel can result in dystocia, or difficult labor, and make vaginal births very painful or 
even impossible for the mother. Previous studies have indicated that cervical ripening precedes 
myometrial contractions by several weeks, suggesting that the process is of long duration, and 
the latter is a late event in the pathogenesis of preterm birth[9] . 
Cervical ripening resembles an inflammatory process in which immune cells, specifically 
macrophages and neutrophils, migrate into the cervix[26]. Increased activity ofmacrophages 
has previously been studied and is thought to be correlated with the breakdown of collagen in 
the cervix, as the cervix is dependent on collagen for its rigidity[13]. This may be attributed to 
macrophages increasing their production of both collagenase, an enzyme that breaks the 
peptide bonds within collagen, and cytokines, chemo-attractant proteins produced and secreted 
by immune cells[2]. The study of the distribution and alterations presented by the neutrophilic 
polymorphonuclear leukocytes in a study performed by Junqueira et al. suggest that neutrophils 
may have an important role in the process of cervical ripening[ II]. Additionally, there is 
growing evidence that leukocyte influx is associated with cervical ripening at birth. In guinea 
pig experiments, monocytes and neutrophils are observed after normal ripening at term[13]. 
Because the neutrophil is a major source of collagenase, specifically MMP8, and the cervix is 
dependant on collagen for its rigidity, cervical ripening has been hypothesized to be 
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accompanied by an influx ofneutrophils[13]. In many cases, a positive relationship between 
the amount of infiltrated cells (neutrophils) and the degree of collagenolysis (cervical tissue 
breakdown/cervical softening) could be observed(ll]. This data suggests that the initiation of 
birth could involve the neutrophil's chemotactic agents[13]. Therefore, it is likely that these 
enzymes play a pivotal role in tissue remodeling during cervical ripening. 
Past research suggests that we need to study more about the mechanism of progesterone's 
actions in regulating cervical remodeling in order to understand these processes. It is well 
documented that the steroid gonadal hormone progesterone plays a central role in the 
reproductive events associated with establishment and maintenance of pregnancy[ 5]. 
Progesterone's actions have been interpreted as blocking myometrium stimulants and inhibiting 
cervical tissue breakdown[ 15]. Pre' ious research has shown that an inflammatory process plays 
an important role in the cervix during parturition. Because progesterone is found to inhibit the 
release of inflammatory cytokines it may, therefore, act as an immunosuppresor in the cervix 
during pregnancy[?]. 
Progesterone plays a dominant role during much of pregnancy, and the withdrawal of 
progesterone's functions appears to be essential for parturition to commence. The actions of 
progesterone are mediated by multi-protein complexes that include progesterone-binding 
components (receptors) that modify components (coregulators and adaptors) and effector 
proteins[28]. The classically accepted mechanism of progesterone action involves a genomic 
pathway involving nuclear progesterone receptors. It is hypothesized that progesterone binds 
to nuclear receptors on the cell nuclei of the cervix and uterus which alters gene expression and 
allows for maintenance ofpregnancy[l]. There are currently two known isoforms ofthe nuclear 
progesterone receptors that exist in humans: PRA and PRB. The PRB isoform contains an extra 
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164 amino acids over the PRA isoform; however functional differences remain uncertain. The 
significance in changing PR and coregulator activities in functional progesterone withdrawal 
can be assessed by the determination of whether similar changes occur in animals that deliver 
after the systemic withdrawal of the hormone[28]. In studies by Zakar et al., PRB does not 
seem to be essential for pregnancy maintenance in mice, and PRA may mediate the action of 
progesterone in the murine uterus during pregnancy. Further studies are currently being 
performed in order to better understand the specific functions that each nuclear isoform plays in 
maintenance of pregnancy[28]. 
In most non-primate placental mammals, the withdrawal of progesterone before the 
initiation of labor is manifest by a significant drop in circulating progesterone levels, which is 
due to either luteolysis or changes in placental 
steroidogenesis, which shunts precursors towards estrogen 
production. However, no such events can be demonstrated 
in human pregnancy[28]. Since systemic progesterone 
levels do not fall in women before birth, this does not ··. 
account for the initiation oflabor[13]. Instead, a theory of 
P J.Ituritio-, 
"functional progesterone withdrawal" has been proposed. The idea simply hypothesizes that the 
uterus and cervix gradually lose the capability to respond to progesterone's effects, and as a 
result cervical ripening occurs despite systemic progesterone levels remaining high in the 
human body[28]. 
Because mice share such close physiological similarities to humans, mice were used as 
the experimental model in this study. We were able to use mice even though they show a drop 
in plasma progesterone levels because of the idea of the "functional progesterone withdrawal" 
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in humans. Additionally, mice share many physiological systemic similarities with humans 
including the reproductive, immune, endocrine and nervous systems. Rodents have long served 
as experimental models for studies of reproduction in mammalian species. Researchers are able 
to study these rodents because of the similarities that exist between the murine and human uteri 
including the multiple structural parallels in the cervix across species regarding collagen 
content and function. For these reasons, it was practical to assume that studies performed on 
mice would easily translate to outcomes that could be tested on humans in the future, allowing 
us to use the mouse as the practical model for this study. Studies have proven that rodents are 
useful for understanding the role of progestational agents in preterrn parturition [26]. 
Furthermore, mice tend to have a highly predictable gestational period, around 19-21 days [9]. 
Their predictable gestational period allows researchers to easily predict outcomes and 
understand results concerning pregnancy, and parturition. The strain used in this study was the 
CD-1 mouse strain which has a normal gestation period of 18-19 days. It is important to note 
that because these mice were out-bred, their date of parturition was not as consistent as other 
strains might have been. However, CD-1 mice were used in this study despite this discrepancy 
because this strain has been used in previous studies and produced predictable results regarding 
pregnancy and parturition date using progestagens as well as more precise capsule doses which 
will be discussed in greater detail in the methods section[20]. 
The capability of progestational agent treatment to block ripening of the cervix and, as 
previously reponed, arrest preterm birth, adds to accumulating evidence that progesterone may 
be effective early in the process to prevent preterm birth[26]. Previous studies by Shi et al. 
show that treatment with the pure progesterone agonist (only binds to the progesterone 
receptor), promegestone (R5020), \Vas successful at maintaining an unripe cervix in pregnant 
10 
Stutz 111 
rats[22]. Previous research in this study by Jaclyn Cooperrider, lead to the conclusion that 
R5020 was also successful at maintaining an unripe cervix in 
ovariectomized mice as well. This data indicates that a compound 
capable exclusively of binding to progesterone receptors is able to 
maintain pregnancy, which suggests that the progesterone receptor 
explicitly plays a role in the maintenance of pregnancy. In a study 
by Yellon et al., progestational agonist treatment was found to 
forestall the endotoxin-induced immigration of neutrophils associated with cervical 
ripening[27]. It is well known that progesterone has a strong binding affinity for both 
progesterone receptors and glucocorticoid receptors. Additional research has illustrated that the 
progesterone hormone and other progestagens, such as medroxyprogesterone acetate, possess a 
strong mixed binding affinity for both the progesterone receptor and the glucocorticoid receptor 
[19]. Additionally, Dexamethasone, a pure corticosteroid capable of 
binding only to glucocorticoid receptors, has been studied by Challis et al. to treat pregnant 
rabbits in order to investigate its role in determining gestational length. Researchers found that 
treatment with dexamethasone in rabbits resulted in premature delivery[3]. However, because 
glucocorticoid receptor agonists have not yet shown an ability to mediate either maintenance of 
pregnancy or cervical ripening on their own, it is unlikely that the binding of progesterone to 
the glucocorticoid receptor alone will result in the receptor playing a role in these 
processes[l2]. 
This particular study explored the activation of glucocorticoid receptors and their 
effect on neutrophil census in the cervix ofpregnant mice. The purpose of this study was to 
determine if the glucocorticoid receptor agonist is able to maintain pregnancy through 
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sustaining an unripe cervix and whether or not the glucocorticoid receptor agonist would be an 
acceptable treatment to prevent preterm birth. We wanted to explore this idea because no other 
studies have been performed regarding the morphology and structure of the cervix after 
glucocorticoid agonist treatment. Based on previous research, it is unlikely that the 
glucocorticoid receptor agonist alone will maintain pregnancy and forestall preterm birth [27]. 
However, it may be possible that the combination of both progesterone and glucocorticoid 
receptor activation could in fact forestall preterm parturition and facilitate maintenance of an 
. . 
unnpe cervix. 
Despite the fact that progesterone treatment alone has produced positive results in the 
maintenance of pregnancy, supporting a strong argument for a 
solely progesterone receptor-mediated mechanism, it is likely 
that progesterone's strong binding affinity for the 
glucocorticoid receptor plays a role in the mechanism as well. 
It is possible that the mechanism of action on the cervix by 
which the mixed progesterone/glucocorticoid receptor agonist, 
medroxyprogesterone acetate (MP A), acts may not be the same 
as the effects ofthe pure glucocorticoid receptor agonist, 
Dexamethasone (Dex). The glucocorticoid agonist may block 
the neutrophil recruitment but not inhibit the degradation of the 
collagen content and structure. This could lead to the novel 
discovery that neutrophil recruitment is not essential for 
Medroxyprogesterone acetate, MPA, is a 
mixed progesterone/glucocorticoid receptor 
agonist. It acts identi;;a!ly to progesterone 
and binds to both the PR and GR. 
Dexamethasone, Dex, is a pure 
glucocorticoid receptor agonist. It 
acts identically to progesterone but 
oniy binds to the GR and not the PR. 
cervical remodeling. The possible involvement of the glucocorticoid receptor must not be 
ignored and thus, explored to aid in the full explanation of the mechanism which mediates 
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preterm cervical ripening and parturition. Thus, the purpose tested in this study investigated the 
role of the glucocorticoid receptors and their effect on date of birth, remodeling of the 
extracellular matrix, and immune cell census in pregnant mice. Our hypothesis was then: the 
glucocorticoid receptor with the progesterone receptor regulates the neutrophil immigration in 
the mechanism for remodeling of the cervix and preterm parturition. 
Experimental Design and Methods 
Animals, Surgeries, and Treatments 
Time-dated pregnant CD-1 mice were ordered from Harlan-Sprague Dawley and 
delivered to the lab on day 15 of gestation. On day 16, these mice were ovariectomized in order 
to eliminate their natural source of Estrogen and Progesterone. Preparation for surgery included 
anesthetizing the mice with isofluorine, shaving their back and cleaning the exposed skin with 
ethanol and betadine. Ovarectomies were performed by making a small, 5-1 Omm, incision in 
the mouse's back and a second incision through the interperitoneal cavity directly below the 
first incision. Ovaries were identified by their small, spherical shape and white color. The 
uterine horn was then transected just below each ovary using surgical scissors. The 
interperitoneal cavity was closed with sutures. Silastic capsule implants were placed in between 
the cavity wall and the skin; the skin was then closed. There were no obvious effects from the 
surgeries on the mice or their offspring which was consistent with published observations [27]. 
Mice were distinguished by the treatment they received post-ovariectomy. The first group 
served as a control and was subjected to the same physical stress of the surgery including 
preparation, incisions, peanut oil-filled vehicle implants, sutures, and staples without removal 
of their ovaries; this group was termed the Sham Control Group. This group served as the 
control for normal cervical remodeling and term birth. Sham mice were expected to give birth 
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on day 19, the proposed day of normal term birth. The second group also served as a control. 
Mice in this group \\'ere ovariectomized unlike the sham group and had a silastic capsule filled 
with peanut oil was placed between the interperitoneal cavity and the skin. Because mice in this 
group undenvent ovariectomies and no further treatment, this group was labeled Ovx. A third 
group underwent the bilateral ovariectomy and was then injected with medroxyprogesterone 
acetate (MPA), a mixed progesterone receptor/glucocorticoid receptor agonist. This group was 
referred to as MP A and received treatment at a concentration of 10 mg/kg/day[ 6]. The final 
group was injected with a pure glucocorticoid agonist, dexamethasone (Dex) after the bilateral 
ovariectomy. This group was termed Dex and was treated at a concentration of 4 mg/kg/day[4]. 
Table 1. Postbreeding day treatments, cervix harvest (X), and birth 
Group Day 16 Day 16.5 Day 17 Day 18 Day 19 
Sham Control Surgery X (PreP) X (PreP) X (PreP) X (PP) 
I 
Ovx Control Surgery X (PreP) X (PP) 
MPA Surgery X (PreP) X (PreP) X (PP) 
Dex Surgery X (PreP) X (PP) 
I 
Capsule Preparation 
Capsules were prepared using Silastic tubing (1.57mm inside diameter x 3.18 mm outside 
diameter- manufactured by Coming) and polyethylene tubing (1.57 mm inside diameter x 2.08 
mm outside diameter - manufactured by Clay 
Adams). Research has previously determined that 
I 
these capsules are capable of being used in studies fl~,·~·l 
I . 
. I 
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regarding the maintenance of pregnancy[21]. Tubes 
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were cut in order to produce steroid-filled silastic capsules. The tip of a hot glue gun was used 
to heat-seal the tube. Vehicle capsules, used in Ovx mice, were filled with plain peanut oil 
using a 1 rnL Tuberculin Syringe with an 18 gauge needle and were cut to 1 ern long[ 18]. The 
other end of the capsule was then heat-sealed-sealed at the end of injection and washed in 90% 
ethanol to sterilize. Capsules were immersed in phosphate buffered saline (PBS) for 24-hours 
incubation period prior to implantation in order to create a salt/pH balance that increased the 
chances for successful implantation of the capsule in the mouse. 
Injections and Implantations 
Ovx mice treated with progestational agonists were injected subcutaneously into the 
dorsum ofthe neck on gestational day 16. Mice given the progesterone/glucocorticoid receptor 
agonist treatment were injected with a 10 mg/kg concentration ofMPA[6]. Those treated with the 
pure glucocorticoid agonist, were injected with a 4mg/kg concentration ofDex[4]. Capsules 
containing peanut oil vehicle were inserted into Ovx Control mice subcutaneously in the dorsal 
rump ofthe neck via a srnall1 -2 mm incision between the scapulas [27]. 
Tissue Collection and Processing 
After ovariectomy and treatment, mice were euthanized with C02 on days 16.5, 17, 18, 
18.5, or 19. The abdomen of each mouse was incised to access the abdominal and thoracic 
cavities. Upon visualization of the thoracic cavity, blood was drawn from the heart to determine 
serum progesterone and cortical levels. Following blood draw, the abdominal cavity was 
exposed to visualize the uterine horns and cervix. The cervix, attached to roughly 1mm of the 
lower portions of the left and right uterine horns, was excised and post-fixed in 4% 
paraformaldehyde. Fixed tissues were embedded in paraffin, which allowed for easier 
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sectioning of the tissue, blocked, cut in 10 11m longitudinal sections, and placed onto glass 
slides for processing. 
Immunohistochemical Staining: 
The prepared slides were processed by immunohistochemistry to identify neutrophils 
with the 7/4 antibody. Slides were heated at 60°C for 30-60 minutes to attach sections to the 
slides. Slides were then subjected to two 10-minute incubation periods with xylene, washed 
twice for 3 minutes at a time with 100% ethanol followed by 90-95% ethanol for two 3-minute 
periods. Next, the slides were incubated for two 3-minute washes in 70-75% ethanol; the 
process ended with one 2 minute rinse in deionized water in order to remove paraffin. In order 
to maintain a water resistant boundary around the tissue, a pep pen was used. The tissue then 
underwent a 2 minute incubation period using proteinase K for 2 minutes, 15 minute incubation 
with 3% hydrogen peroxide and finally, three 5-minute washes with PBS. Slides were then 
placed in a blocking serum (10% goat serum, 3% ofO.l solution Triton-X) for 30 minutes and 
subsequently incubated in a 0.01 mg/ml concentration of the 7/4 antibody for 90 minutes before 
undergoing three more 5-minute rinse periods with PBS. 
Next, the slides were incubated with biotyinylated anti-rat secondary antibody in a 1% 
concentration for 30 minutes and washed in three additional 5-minute periods of PBS. ABC 
and DAB (3,3-Diaminobenzidine) substrates were added with PBS washes in between. Slides 
were stained with hematoxylin (a nuclear stain which stains cell nuclei purple) for 2 seconds. 
The slides were then rinsed in running water for 15 minutes. Lastly, the tissue was dehydrated 
by two 5-minute rinses in 75% ethanol, two 5 minutes rinses in 95% ethanol, two 5 minutes 
rinses in 100% ethanol, and two 1 0-minute rinses in xylene. 
16 
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Analysis of Data 
Once the slides were stained and dried, images of the tissue sections were taken using a 
Zeiss microscope Axio Imager Al and the Spot Advanced program. Eight non-overlapping 
images were taken on three different tissue sections per animal, allowing for a total of 24 
images per animal. This allowed accurate and representative sampling of the cervical tissue and 
decreased bias in the counts. 
Images were then stored and analyzed using Image Pro Plus 6.0. Neutrophil counts were 
then performed manually based on color, shape and size of 7/4 antibody (brown) stained areas. 
Cell nuclei counts were also performed manually based on color, shape and size ofhematoxylin 
(purple) stained areas. Counts were then recorded in an Excel spread sheet and normalized to 
cell nuclei density. This data was analyzed using the "Graph Pad Prism" statistical computer 
program. Levene's test, one-way Analysis ofVariance (ANOVA) and appropriate t-tests were 
performed to identify statistical differences between the four groups. 
Results: 
17 
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Figure 1, Progesterone Withdrawal Induces Preterm Birth. Day of parturition post-breeding for mice that were 
Sham-operated, Ovx, or ovariectomized and treated with Medroxyprogesterone Acetate (MP A) or Dexamethasone 
(Dex). * p <0.05 vs Sham group. Each bar represents the mean day of birth (±SE, number of mice/group specified) 
for that group. Where SE not shown, births occurred on the day indicated. A probability of *p<0.05 was used to 
determine significance between groups. Date of surgery indicated by red line, while normal term birth in blue line 
is based upon our previous reports [ 17}. 
Sham-operated mice deliYered on gestational day 18 and 19. As expected, mice in the 
ovariectomy control group all gave birth on day 17, approximately 1-2 days prior to normal 
term delivery. Mice that underwent ovariectomies and later treated with MPA delivered on 
days 18 and 19 post-breeding, similar to the Sham control group. Dexamethasone treated mice 
experienced parturition on day 17, much like that of the ovariectomy control group (Figure 1). 
A one-way ANOV A of this data revealed that both the Ovx control group and Dexamethasone 
group were statistically different (p < 0.05) from the Sham-operated control. 
18 
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Figure 2. Neither PR nor GR affect remodeling of the extracellular matrix (ECM). Optical density of 
the ECM in prepartum and postpartum mice subjected to Sham treatment, ovariectomy (Ovx), ovariectomy followed 
by Medroxyprogesterone Acetate (MPA) or Dexamethasone (Dex). Optical Density data was normalized to cell 
nuclei density in order to account for tissue hypertrophy of the cervix that occurs in the normal process of 
pregnancy. Each bar represents the mean optical density to cell nuclei density per 11m3 of tissue (±SE, number of 
mice/group specified). & p < 0.05 vs. Dl6.5 Dex 
Optical density data shows that neither activation of the PR or the GR is involved in 
ECM remodeling. This result can be seen through the lack of significant difference between 
groups treated with PR or GRand Sham. Data does demonstrate a slight significant different 
between D16.5 Dex and PP Dex groups however this may be due to the decreased of variability 
and smaller SE bars within the dexamethasone group as well as the decreased mean within the 
D16.5 Dex group. Dexamethasone has been noted to have an anti-inflammatory effect, which is 
why, D16.5 in this group has a lower optical density and greater collagen content. It is important 
to note that this data shows that dexamethasone is promoting more collagen and more structure 
within the cervix. However, based on previous research by Yellon et. al. the D16.5 cervix has 
ripened relative to a non-pregnant cervix and is sufficient for parturitionAdditionally, D16.5 is 
approximately 8 hrs after treatment with the GR agonist, whereas the postpartum group is 24 hrs 
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after treatment leading us to believe that this increase in OD may be related to dexamethasone 
wearing off. At this time, there is no clear evidence to support this hypothesis. It is important to 
note that the dexamethasone postpartum group is not significantly different from any of the other 
PP groups (Sham, Ovx, or MP A) suggesting that this statistical difference may not be 
biologically important for the process that remodels the cervix. No significant difference was 
found across postpartum groups using a one-way ANOV A (Figure 2). 
6 Sham Ovx MPA 
16.5 17 pp 16.5 pp 16.5 18 pp 
.Dex 
b 
16.5 PP 
Figure 3. GR agonist inhibits hypertrophy of cervix by day before birth. Cell nuclei counts in 
prepartum and postpartum mice subjected to Sham treatment, ovariectomy (Ovx), ovariectomy followed by 
. ledroxyprogesterone Acetate (:t'viPA) or Dexamethasone (Dex). Each bar represents the mean cell nuclei density per 
!1m3 oftissue (±SE, number of mice/group specified). b p < 0.05 vs. Dl7 Sham, &. vs. 016.5 Dex. 
Cell nuclei analysis provides data supporting that treatment with a GR agonist inhibits the 
hypertrophy of the cervix associated with normal term birth by the day before birth. Previous 
research in our laboratory has noted that D 15 mice show a cell nuclei count of approximately 7 
!-lrn3 x 103. Because of this, we have reason to believe that treatment with dexamethasone blocks 
the drop to 4 ~tm3 x 103 that is seen in the other groups (Sham, Ovx, and MPA) b) D16.5, 
20 
Stutz 1 21 
indicating an inhibition of the growth within the cervix. As previously stated, dexamethasone is 
known to have anti-inflammatory effects, therefore it would be expected that Dex D16.5 would 
be have a higher mean demonstrating decreased growth. Additionally, the mean of D 16.5 cell 
nuclei is much higher than D 16.5 in the other groups suggesting that the significant difference 
seen between D16.5 and the postpartum cervix in the dexamethasone group could be due to the 
decreased variability seen with treatment of Dexamethasone. The postpartum Dexamethasone 
group is not significantly different from Sham, Ovx or MP A suggesting that the cervix grows 
and stretches independent of the treatment received. No significant difference was found across 
postpartum groups using a one-way ANOV A (Figure 3). 
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Figure 4, Progesterone Withdrawal, Along with PR & GR Agonists, Prevents Neutrophil 
Immigration. Neutrophil census in prepartum and postpartum mice subjected to Sham treatment, ovariectomy 
(Ovx), ovariectomy followed by Medroxyprogesterone Acetate (MPA) or Dexamethasone (Dex). Neutrophil counts 
were normalized to cell nuclei density in order to account for tissue hypertrophy of the cervix that occurs in the 
normal process of pregnancy. Each bar represents the mean neutrophil census normalized to cell nuclei density per 
)lm3 of tissue (±SE, number of mice/group specified). "p < 0.05 vs. D 16.5 Sham, b vs. D17 Sham, c vs. PP Sham, & 
vs. Dl6.5 Dex. 
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Neutrophil counts displayed trends against what was previously speculated (see Figure 
2). The census ofneutrophils in the cervix increased by day of birth in Sham controls, which was 
expected. However, analysis between prepartum and postpartum groups for the Ovx and MPA 
groups using an unpaired t-test shmved no statistical differences. This indicates that neutrophil 
numbers were unchanged in the cervix of mice after Ovx or MP A treatment, i.e. after 
progesterone withdra\val or progestational agonist treatment. Interestingly enough, an unpaired t-
test between the day before birth (017) in the Sham group and day before birth (016.5) in the 
Dex group revealed a significant decrease in the number of neutrophils present after treatment 
with dexamethasone (p=0.0728). A significant decrease was discovered within the Dex group 
between prepartum and postpartum. Therefore, treatment with Dex, reduced neutrophils in the 
prepartum cervix. Again data demonstrates differences between 016.5 and PP Oex cervix. This 
is due to the decreased variability and smaller SE bars within the group. This again illustrates the 
consistent rebound effect across the data (seen in optical density, collagen data and neutrophil 
data) where dexamethasone wears off and the postpartum group is within the range of the normal 
controls. A one-way ANOV A within the prepartum group showed no significant difference 
across groups. Similarly, no significant difference was found across postpartum groups using a 
one-way A!"\JOVA (Figure 4). 
Discussion: 
Findings in this study do not support the hypothesis that neutrophils are involved in the 
process of preterm remodeling of the cervix and/or parturition. In fact, data supports the 
alternative hypothesis . The lack of change in neutrophil numbers in the cervix before or after 
birth following progesterone \Vithdrawal (Ovx) or receptor agonist treatment (MPA) after 
withdrawal does not support the hypothesis that the PR and GR, together, are involved in the 
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neutrophil recruitment that is associated with normal term remodeling of the cervix. 
Additionally, data supports that activation of the progesterone receptor, without activation of the 
glucocorticoid receptor, is capable of blocking the neutrophil recruitment and preventing preterm 
birth. 
To determine the effects of progesterone withdrawal along with progestational agonist 
treatment, parturition days between groups were compared (Figure 1 ). Previous research on the 
Sham group leads us to expect normal term birth to occur on day 19 only[20]. However, CD1 
mice delivered on days 18 and 19 post breeding. This did not prevent conclusions about the 
ability for these mice to maintain pregnancy because this outcome was a result of natural 
progesterone levels and natural processes in the body (because Sham mice did not have their 
ovaries removed). This information and statistical analyses performed versus the Sham control 
supported that the MP A group displayed the ability to maintain pregnancy through normal term 
and that progesterone withdrawal with a glucocorticoid agonist stimulated cervical ripening and 
preterm birth. 
The ability of MP A to maintain pregnancy until normal term and inhibit the neutrophil 
recruitment associated with normal term cervical ripening indicates that a synthetic compound, 
which binds to both the progesterone receptor and the glucocorticoid receptor, would be able to 
maintain pregnancy (Figure 1, 2). Additionally, previous data in this study with R5020, a pure 
progesterone receptor agonist, demonstrated similar results suggesting that a progesterone 
receptor mechanism is responsible for maintaining pregnancy and blocking preterm cervical 
ripening. It was also noted that treatment with a pure glucocorticoid receptor agonist, 
Dexamethasone, induced preterm parturition and did not prevent the neutrophil immigration by 
the day ofbirth (Figure 1, 4). 
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In order to determine the mechanism by which pregnancy is maintained and preterm 
parturition occurs, optical density of the extracellular matrix, cell nuclei counts, and neutrophil 
counts were performed. 
Optical density data through analysis of the extracellular collagen matrix (ECM) 
demonstrated that neither activation of the progesterone receptor (MPA) or the glucocorticoid 
receptor (Dex) affected the collagen density in the cervix, leading to the conclusion that it is 
possible the ECM is not affected by progesterone or glucocorticoid receptors and remodels in a 
mechanism independent ofthese receptors (Figure 2). Additionally, treatment with 
progestational agonist, MP A, did not show a decrease in cell nuclei when comparing prepartum 
and postpartum cervix, which suggests that the cervix grows in a similar mechanism to Sham 
after treatment with MPA (Figure 3). It is important to note that the major differences usually 
seen regarding the hypertrophy of the cervix are seen between Dl5 and D18. Our lab is currently 
in the process of obtaining data from these days. However, cell nuclei data demonstrated that 
treatment with Dex inhibits the hypertrophy of the cervix. 
Analysis of neutrophils demonstrated that the mechanism of normal term birth is 
associated with an infiltration ofneutrophils into the cervix by the day of birth. However, 
progesterone withdrawal (Ovx) and progestational agonist treatment (MP A) inhibit the 
neutrophil immigration associated with normal term birth as seen in the Sham group (Figure 4). 
Data from this study suggests that the mechanism of preterm birth may work through a 
mechanism, which does not involve neutrophils because neither progesterone withdrawal or 
progesterone receptor and glucocorticoid receptor agonist treatment prevents neutrophil 
recruitment by the day of birth. Since MP A sustains pregnancy and forestalls cervical 
24 
remodeling through a neutrophil-independent mechanism, findings indicate that other 
inflammatory cells may regulate cervical remodeling. 
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Furthermore, treatment with Dexamethasone suggests that the glucocorticoid receptor is 
not involved in the mechanisms that regulate growth of the cervix, extracellular matrix 
remodeling or in progesterone withdrawal mediated preterm birth. Therefore, although 
glucocorticoids have anti-inflammatory actions, they are unlikely to be a useful treatment to 
block preterm ripening of the cervix or prevent preterm birth. Rather, data suggests that the 
progesterone receptor is critical to the processes that maintain pregnancy and prevent preterm 
parturition. From this, we can conclude that progestational agents may forestall specific aspects 
of inflammatory-mediated cervical remodeling and maintain pregnancy. 
Although multiple animals were use for this study, not all of them could be properly 
imaged and analyzed for use in the final data set. Some cervices were more feasible for 
sectioning than others. In a minor number of cases, the cervix was not fully intact due to errors 
during surgery and excision of the cervix. As a result of this, some images had multiple holes in 
the tissue, which could not be avoided upon analysis. Because we felt this was not an accurate 
picture of the cervix, these animals were taken out of the study. In the majority of cases, we 
attempted to image areas of the cervix which were fully intact, minimizing the number of holes 
in the photos. In cases where holes were minutely present, but the majority of the cervix was 
intact, cervices were analyzed as accurately as possible. 
Further analysis with other data in this study will need to be obtained and compared to 
determine if progesterone is acting through the progesterone receptor alone, or through the 
combined actions of both the progesterone receptor and the glucocorticoid receptor. Future work 
will include flow cytometry to determine if the known inflammatory response is due to activation 
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of neutrophils already present in the cervix rather than an immigration of neutrophils into the 
cervix. Once concrete conclusions can be drawn based on the results of this study, future studies 
can be aimed at determining if pure progesterone agonists, such as R5020, work through the 
same mechanisms to maintain pregnancy as progesterone. If and when future studies do establish 
the mechanism by which both normal term and pre-term pregnancy occurs, pharmacological 
studies can be used to determine possible ways to prevent pre-term birth from occurring 
26 
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